LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 44 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 59,956,000 | $49,653,000 | 4.88% |
| SYMPHONY ASSET MANAGEMENT LLC | 18,000,000 | $14,906,000 | 4.68% |
| CANYON CAPITAL ADVISORS LLC | 60,000,000 | $49,708,000 | 1.76% |
| Venator Capital Management Ltd. | 1,500,000 | $1,250,000 | 1.28% |
| Context Capital Management, LLC | 2,350,000 | $1,968,000 | 1.12% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $18,577,000 | 0.50% |
| OAKTREE CAPITAL MANAGEMENT LP | 18,865,000 | $15,622,000 | 0.44% |
| AQR Arbitrage LLC | 13,431,000 | $11,123,000 | 0.37% |
| SSI INVESTMENT MANAGEMENT LLC | 4,000,000 | $3,303,000 | 0.29% |
| CAMDEN ASSET MANAGEMENT L P /CA | 11,600,000 | $9,577,000 | 0.28% |